CN101785838B - Lung cancer treatment medicine - Google Patents
Lung cancer treatment medicine Download PDFInfo
- Publication number
- CN101785838B CN101785838B CN201010106445XA CN201010106445A CN101785838B CN 101785838 B CN101785838 B CN 101785838B CN 201010106445X A CN201010106445X A CN 201010106445XA CN 201010106445 A CN201010106445 A CN 201010106445A CN 101785838 B CN101785838 B CN 101785838B
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- bletillae
- later stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A lung cancer treatment medicine includes the initial stage medicine and later stage medicine of the disease course; wherein, the raw materials of the initial stage includes: 15-30g of wild chrysanthemum, 13-20g of radix stemonae, 20-30g of bletilla, 20-30g of cogongrass rhizoma (monkshoodvine root-bark) , 30-50g of sculellaria barbata, 15-25g of cynanchum atratum, 20-30g of vitex, 10-20g of tendril-leaved fritillary bulb, 10-20g of thunberg fritillary, 15-20g of rhizoma pinelliae preparata, 20-30g of turtle shell,10-20g of tonkinensis and 10-20g of codonopsis ussuriensis hemsl; the raw materials of the later stage medicine include:20-30g of bletilla, 15-20g of radix ampelopsis, 20-30g of gecko, 20-30g of asparagus,15-20g of radix ophiopogonis, 20-30g of polygonatum, 15-20g of dysosma, 15-30g of indian iphigenia bulb, 20-30g of radix semiaquilegiae, 20-30g of adenophora stricta,20-30g of cortex lycii radicis,15-25g of oyster, 15-25g of gypsum, 30-50g of oldenlandia diffusa, 10-20g of momordica dioica. The lung cancer treatment medicine is used for the treatment of 250 cases, wherein 80 cases are cured, significant efficacy is shown in 162 cases and no efficacy is found in 8 cases so that the cure rate is 32%, the significant efficacy rate is 64.8%, the non-efficacy rate is 3.2% and the total efficacy rate is 96.8%.
Description
[technical field] the present invention relates to a kind of treatment lung cancer drugs, belongs to technical field of Chinese medicines.
[background technology] pulmonary carcinoma is one of common malignancy, and its M & M all has tangible ascendant trend, and the probability that the tool report is suffered from pulmonary carcinoma at present is 3 ‰, suffers from the survival rate of pulmonary carcinoma more than 5 years and is no more than 10%.Doctor trained in Western medicine adopts operation, radiotherapy or chemotherapy usually to the Therapeutic Method of pulmonary carcinoma at present; Its therapeutic effect is not satisfied; Though and Chinese traditional treatment pulmonary carcinoma has the history of more than one thousand years, because of the cause of disease of pulmonary carcinoma is complicated, the dialectical diagnosis and treatment standard that does not have a cover to generally acknowledge; Each traditional Chinese medical science is all treated by separately opinion and method medication; Because of pulmonary carcinoma has spleen emptiness and wet sputum type, the expectorant stasis of blood stagnate type, qi stagnation and blood stasis type, type of YIN-deficiency and interior-heat, type of deficiency of both QI and YIN, lung suffer from a deficiency of the kidney thanks to type and deficiency of both YIN and YANG type or the like, if poor effect is not often suited the medicine to the illness in medication.
Still there is demand in the Chinese medicine preparation that [summary of the invention] present people better treat pulmonary carcinoma to curative effect; Up to now; Also do not have to find that inhomogeneity pulmonary carcinoma is had the medicine than standard, the inventor from little just when Chinese medicine on foot, dig medicine, pharmacy, medication, nearly 60 years treatment practice is arranged; Finally work out a kind of oral medicinal herb medicine of treating pulmonary carcinoma, thereby accomplished the present invention.
The purpose of this invention is to provide a kind of Chinese medicine composition of treating pulmonary carcinoma.Medicine of the present invention divides course of disease initial stage medicine and course of disease later stage medicine; Initial stage is main to choose the dry Chinese medicine of heat-clearing and toxic substances removing of reducing phlegm and internal heat; Later stage is that Chinese medicine is main to select regulating yin and yang, opening lung-energy, blood circulation promoting and blood stasis dispelling, blood stasis dispelling, hard masses softening and resolving, removing dampness by means of aromatics, strengthening vital QI to eliminate pathogenic factors, strengthening the spleen and nourishing the stomach for use, and wherein the in the initial stage of that the medicine chosen has:
Flos Chrysanthemi Indici 15 ~ 30g, the Radix Stemonae 13 ~ 20g, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20 ~ 30g, Rhizoma Imperatae (another name Cortex Ampelopsis Aconitifoliae Radicis) 20 ~ 30g, Herba Scutellariae Barbatae 30 ~ 50g; White little 15 ~ 25g, five-leaved chaste tree 20 ~ 30g, sharp shellfish 10 ~ 20g, Bulbus Fritillariae Thunbergii 10 ~ 20g; Method for making summer 15 ~ 20g, Carapax Trionycis 20 ~ 30g, Radix Sophorae Tonkinensis 10 ~ 20g, Radix Codonopsis lanceolatae 10 ~ 20g;
The medicine that later stage is chosen is:
The Pseudobulbus Bletillae (Rhizoma Bletillae) 20 ~ 30g holds back 15 ~ 20g in vain, Gecko 20 ~ 30g, Radix Asparagi 20 ~ 30g; Radix Ophiopogonis 15 ~ 20g, Rhizoma Polygonati 20 ~ 30g, Radix et Rhizoma Dysosmatis 15 ~ 20g, Pseudobulbus Cremastrae Seu Pleiones 15 ~ 30g; Radix Semiaquilegiae 20 ~ 30g, Radix Adenophorae (Radix Glehniae) 20 ~ 30g, Cortex Lycii 20 ~ 30g, Concha Ostreae 15 ~ 25g; Gypsum Fibrosum 15 ~ 25g, Herba Hedyotidis Diffusae 30 ~ 50g, dioecism momordica root 10 ~ 20g.
Medicine of the present invention can take the conventional method of Chinese medicine preparation to process any conventional oral preparations; As being decocted, the Chinese medicine water processes decoction; Or Chinese medicine powder is broken into powder; Process powder behind the mix homogeneously or add conventional adjuvant again and process pill, tablet or capsule, eat a chive fried egg when taking medicine earlier, effect can be better.
Chinese medicine of the present invention is divided into the method for treatment of pulmonary carcinoma in treatment: initial stage and later stage medicine, the Chinese medicine of employing promoting flow of QI and blood, dissipating blood stasis, removing toxic substances and promoting subsidence of swelling, tonifying kidney and nourishing yin, QI invigorating and blood producing is treated targetedly, has further improved the effect and the cure rate of treatment.Through clinical use for many years, effective percentage is more than 96.8%, and cure rate reaches 32%, has received satisfied effect.
[specific embodiment] following beneficial effect of further setting forth Chinese medicine of the present invention through clinical observation material:
1, physical data
Treat patients with lung cancer 250 examples altogether, male 150 examples, women 100 examples, the age is in 30-65 year.
2, diagnostic criteria
Cough is many, and companion's pus and blood expectorant, abundant expectoration are thick and glutinous, out of breath uncomfortable in chest, dyspnea with shortness of breath, and fullness and distention in the chest and hypochondrium, chest pain has many places, spiritlessness and weakness, emaciated physique is obvious, and low grade fever night sweat or spontaneous perspiration are diagnosed as pulmonary carcinoma through photo.
3, Therapeutic Method
With each clothes 200 grams of Chinese medicine decoction of the present invention, 3 times on the one, one after each meal, every dose of clothes were a course of treatment in 30 days.Can cure general 3 ~ 6 courses of treatment.
4, efficacy assessment standard
Cure: after taking medicine 3 ~ 6 courses of treatment, all symptoms of pulmonary carcinoma performance all have alleviating or takes a turn for the better in various degree, and after continuing to take medicine, appetite is cumulative again, progressively recover sick before body weight, entering normal person quality of life, and confirm as normal person through x-ray fluoroscopy.
Produce effects: through taking the present invention after 30 days, more relevant symptoms begin to improve, and like pain relief, the cough spitting of blood reduces, and breathe hard, asthma, uncomfortable in chest, fullness and distention in the chest and hypochondrium, night sweat or spontaneous perspiration symptom also take a turn for the better trend to some extent.Take this medicine again after 30 ~ 50 days, above-mentioned symptom has further alleviation again, and appetite has and increases, and health slightly increases weight, and quality of life also increases, but fails to cure.
Invalid: after taking medicine of the present invention, all symptoms all do not have improvement.
5, result
Treat 250 examples, cure 80 examples, produce effects: 162 examples, invalid 8 examples, cure rate 32%, obvious effective rate 64.8%, inefficiency 3.2%, total effective rate 96.8%.
Introduce the prescription and the method for making of a typical decoction below:
One, selects following crude drug for use
Flos Chrysanthemi Indici 25g, Radix Stemonae 15g, Pseudobulbus Bletillae (Rhizoma Bletillae) 25g, Rhizoma Imperatae (another name Cortex Ampelopsis Aconitifoliae Radicis) 25g, Herba Scutellariae Barbatae 40g, Bai Wei 20g, five-leaved chaste tree 25g, sharp shellfish 15g, Bulbus Fritillariae Thunbergii 15g, method for making summer 18g, Carapax Trionycis 25g, Radix Sophorae Tonkinensis 15g, Radix Codonopsis lanceolatae 15g is the initial stage curative;
Two, above-mentioned raw materials liquid medicine is fried in shallow oil 3 times, mixed to divide one day after and drink for three times, serve on 30 days.
Three, the following later stage medicine of reuse, every day, one pair raw material dose decocte with water was 3 times, and each 20 minutes, three times medicinal liquid mixed the back branch and takes for three times.
Pseudobulbus Bletillae (Rhizoma Bletillae) 25g holds back 18g in vain, Gecko 25g, Radix Asparagi 25g, Radix Ophiopogonis 18g, Rhizoma Polygonati 25g, Radix et Rhizoma Dysosmatis 18g, Pseudobulbus Cremastrae Seu Pleiones 20g, Radix Semiaquilegiae 25g, Radix Adenophorae (Radix Glehniae) 5g, Cortex Lycii 25g, Concha Ostreae 20g, Gypsum Fibrosum 20g, Herba Hedyotidis Diffusae 40g, dioecism momordica root 15g.
Four, use admixing medical solutions, every day, one after each meal was three times, and each 300g serve on 50-70 days, treats that patient's whole body plays red little pimple, reach all over body take off white scales entirely more till.
Five, take during hot, the peppery food of fasting, smoking cessation, wine are prohibited sexual life, avoid heavy physical labour.
Six, model case:
1, Gong Qingben, the man, 46 years old, people from Changde City was diagnosed as the pulmonary carcinoma later stage through First People's Hospital, city; In March, 2008-here treatment in JIUYUE, with this medicine, take three months initial stages medicine, reuse is first medicine after 3 months, spends 4500 yuan; During complete healing, of pink and healthy-looking, do not cough, do not burn, can eat and can sleep; Spirit is normal, pays a return visit after 1 year, and health is normal, and the pulmonary carcinoma symptom all disappears.
2, Dai Chengnan, the woman, 48 years old, people from Changde City, the People's Hospital, Changde City is diagnosed as upper left pulmonary carcinoma advanced tumor; Do not receive treatment, her to go back to prepare later age, come the treatment of this out-patient department, adopt above-mentioned early stage and later stage two kinds of cancer curing medicine liquids on May 15th, 2007; Respectively took 90 days, every day, one pair of dose went check on the 10th again in December in 2007, and the cancer disease disappears as a result; Of pink and healthy-looking, do not cough and do not burn, it is normal to have a meal, and walking is freely.
3, Wang Changquan, the man, 52 years old, people from Changde do not have money because of pulmonary carcinoma and cures; This clinic of coming takes traditional Chinese medicine, and is not in hospital, and is in and adheres to taking medicine treatment, one pair of Chinese medicine decoction every day in early stage; Serve on 50 days, reuse later stage Chinese medicine decoction was taken 60 days more continuously, and own sensation is not breathed heavily, do not coughed; Do not burnt, checked to hospital, found tumor calcification on the lung, functional rehabilitation is normal.
Claims (2)
1. a treatment lung cancer drugs is made up of initial stage medicine and course of disease later stage medicine, it is characterized in that: the initial stage medicine is main to choose the dry Chinese medicine of heat-clearing and toxic substances removing of reducing phlegm and internal heat, and the later stage medicine is that Chinese medicine is main to select blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, removing dampness by means of aromatics, strengthening the spleen and nourishing the stomach for use; The medicine material composition that the said initial stage is chosen is: Flos Chrysanthemi Indici 15~30g, the Radix Stemonae 13~20g, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20~30g, Rhizoma Imperatae 20~30g; Herba Scutellariae Barbatae 30~50g, Bai Wei 15~25g, five-leaved chaste tree 20~30g; Point shellfish 10~20g, Bulbus Fritillariae Thunbergii 10~20g, method for making summer 15~20g; Carapax Trionycis 20~30g, Radix Sophorae Tonkinensis 10~20g, Radix Codonopsis lanceolatae 10~20g;
The material medicine of later stage choice of drug is formed: the Pseudobulbus Bletillae (Rhizoma Bletillae) 20~30g, hold back 15~20g, Gecko 20~30g, Radix Asparagi 20~30g in vain; Radix Ophiopogonis 15~20g, Rhizoma Polygonati 20~30g, Radix et Rhizoma Dysosmatis 15~20g, Pseudobulbus Cremastrae Seu Pleiones 15~30g; Radix Semiaquilegiae 20~30g, Radix Adenophorae (Radix Glehniae) 20~30g, Cortex Lycii 20~30g, Concha Ostreae 15~25g; Gypsum Fibrosum 15~25g, Herba Hedyotidis Diffusae 30~50g, dioecism momordica root 10~20g.
2. a kind of treatment lung cancer drugs according to claim 1 is characterized in that: the crude drug composition of initial stage choice of drug is: Flos Chrysanthemi Indici 25g, Radix Stemonae 15g, Pseudobulbus Bletillae (Rhizoma Bletillae) 25g; Rhizoma Imperatae 25g, Herba Scutellariae Barbatae 40g, Bai Wei 20g, five-leaved chaste tree 25g; Point shellfish 15g, Bulbus Fritillariae Thunbergii 15g, method for making summer 18g; Carapax Trionycis 25g, Radix Sophorae Tonkinensis 15g, Radix Codonopsis lanceolatae 15g;
The material medicine of later stage choice of drug is formed: Pseudobulbus Bletillae (Rhizoma Bletillae) 25g, hold back 18g in vain, Gecko 25g, Radix Asparagi 25g, Radix Ophiopogonis 18g; Rhizoma Polygonati 25g, Radix et Rhizoma Dysosmatis 18g, Pseudobulbus Cremastrae Seu Pleiones 20g, Radix Semiaquilegiae 25g, Radix Adenophorae (Radix Glehniae) 5g; Cortex Lycii 25g, Concha Ostreae 20g, Gypsum Fibrosum 20g, Herba Hedyotidis Diffusae 40g, dioecism momordica root 15g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010106445XA CN101785838B (en) | 2010-01-28 | 2010-01-28 | Lung cancer treatment medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010106445XA CN101785838B (en) | 2010-01-28 | 2010-01-28 | Lung cancer treatment medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101785838A CN101785838A (en) | 2010-07-28 |
CN101785838B true CN101785838B (en) | 2012-05-23 |
Family
ID=42529310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010106445XA Expired - Fee Related CN101785838B (en) | 2010-01-28 | 2010-01-28 | Lung cancer treatment medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101785838B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103735957A (en) * | 2013-12-25 | 2014-04-23 | 韩明辉 | Chinese herbal medicine formula for treating benign tumors in lung and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634376A (en) * | 2004-11-09 | 2005-07-06 | 贵州省都匀市剑江药业有限公司 | Compound wild chrysanthemum flower skin bacteria inhibitor and preparation method thereof |
-
2010
- 2010-01-28 CN CN201010106445XA patent/CN101785838B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634376A (en) * | 2004-11-09 | 2005-07-06 | 贵州省都匀市剑江药业有限公司 | Compound wild chrysanthemum flower skin bacteria inhibitor and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101785838A (en) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1927379A (en) | Traditional medicine preparation for treating children's pulmonary disease | |
CN101057960A (en) | Pills for curing stomach-ache | |
CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
CN103341150B (en) | Traditional Chinese medicine preparation for treating chronic gastritis | |
CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
CN100493586C (en) | Oral liquid for treating breast cancer, liver cancer or lung caner, and preparation thereof | |
CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
CN101785838B (en) | Lung cancer treatment medicine | |
CN101444593A (en) | Chinese traditional medical formula taken orally for curing asthma | |
CN103623346A (en) | Traditional Chinese medicine for treating abdominal distention caused after abdominal operation | |
CN103463604A (en) | Drug for treating cough and asthma | |
CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
CN102579787B (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
CN105796891A (en) | Traditional Chinese medicinal composition for treating epigastric pain | |
CN105477452A (en) | Traditional Chinese medicine for treating pulmonary emphysema | |
CN104399040A (en) | Drug for treating gastrectasia and preparation method thereof | |
CN1222364A (en) | Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof | |
CN116350731B (en) | Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof | |
CN101940643B (en) | Medicament for treating gastric cancer and esophagus cancer | |
CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
CN104189315B (en) | A kind of Chinese medicine for the treatment of expectorant blood stasis type globus hystericus | |
CN104815210A (en) | Traditional Chinese medicine for preventing and curing recurrent oral ulceration and preparation method thereof | |
CN105288174A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
CN104147523A (en) | Traditional Chinese medicine preparation for treating cholecystitis | |
CN104027571A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20130128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |